FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3150494001> ?p ?o ?g. }

• W3150494001 abstract "Objective: To evaluate the influence of dexamethasone on the incidence of postoperative nausea and vomiting( PONV) in patients undergoing modified radical mastectomy with neoadjuvant chemotherapy. Methods: In a prospective trial,280 female( 18- 60 years) breast cancer patients undergoing modified radical mastectomy with neoadjuvent chemotherapy were randomized to two groups: one with dexamethasone( Group D) and one without dexamethasone( Group C,n = 140). In each group,anesthesia was maintained with volatile anesthesia or total intravenous anesthesia( TIVA) : TIVA( propofol) without dexamethasone( Subgroup CP); volatile anesthesia( sevoflurane) without dexamethasone( Subgroup CS); TIVA with 10 mg dexamethasone intravenously before anesthetic induction( Subgroup DP); volatile anesthesia with 10 mg dexamethasone intravenously before anesthetic induction( Subgroup DS). A standard general anesthetic technique was used. All the patients received 8 mg of ondansetron intravenously 30 minutes before the end of surgical procedures. The incidence of PONV during the 24-hour postoperative period was recorded. A Logistic regression analysis was conducted to examine relevant factors for PONV. The tested factors were: age,body mass index( BMI),duration of surgery,postoperative pain,history of motion sickness / PONV,with or without dexamethasone and anesthetic regimen.Results: There was a significant lower incidence of PONV in the patients who received dexamethasone than in those who received placebo during the 24-hour postoperative period( 11. 4% vs. 20. 7%,P = 0. 034). In the early postoperative period( 0- 2 h) dexamethasone reduced the incidence of PONV( 1. 4% vs. 6. 4%,P = 0. 031),but in the late postoperative period( 2- 24 h) the difference of the incidence was insignificantly( 10. 7% vs. 17. 9%,P = 0. 088). No differences were found between TIVA and volatile anesthesia in the 24-hour postoperative period. Dexamethasone was effective to prevent PONV( OR = 0. 447,P = 0. 030),and history of PONV or motion sickness was the risk factor of PONV( OR = 15. 730,P 0. 001). Conclusion: Dexamethasone prevents PONV effectively in patients undergoing modified radical mastectomy with neoadjuvant chemotherapy,and TIVA cannot decrease the incidence of PONV in the 24-hour postoperative period in those patients." @default.
• W3150494001 created "2021-04-13" @default.
• W3150494001 creator A5029154704 @default.
• W3150494001 date "2015-01-01" @default.
• W3150494001 modified "2023-09-26" @default.
• W3150494001 title "Influence of dexamethasone on the incidence of postoperative nausea and vomiting in breast cancer patients with neoadjuvant chemotherapy" @default.
• W3150494001 hasPublicationYear "2015" @default.
• W3150494001 type Work @default.
• W3150494001 sameAs 3150494001 @default.
• W3150494001 citedByCount "0" @default.
• W3150494001 crossrefType "journal-article" @default.
• W3150494001 hasAuthorship W3150494001A5029154704 @default.
• W3150494001 hasConcept C121608353 @default.
• W3150494001 hasConcept C126322002 @default.
• W3150494001 hasConcept C141071460 @default.
• W3150494001 hasConcept C2776277131 @default.
• W3150494001 hasConcept C2777297131 @default.
• W3150494001 hasConcept C2780401358 @default.
• W3150494001 hasConcept C2780580376 @default.
• W3150494001 hasConcept C2780852908 @default.
• W3150494001 hasConcept C2780884295 @default.
• W3150494001 hasConcept C42219234 @default.
• W3150494001 hasConcept C530470458 @default.
• W3150494001 hasConcept C71924100 @default.
• W3150494001 hasConceptScore W3150494001C121608353 @default.
• W3150494001 hasConceptScore W3150494001C126322002 @default.
• W3150494001 hasConceptScore W3150494001C141071460 @default.
• W3150494001 hasConceptScore W3150494001C2776277131 @default.
• W3150494001 hasConceptScore W3150494001C2777297131 @default.
• W3150494001 hasConceptScore W3150494001C2780401358 @default.
• W3150494001 hasConceptScore W3150494001C2780580376 @default.
• W3150494001 hasConceptScore W3150494001C2780852908 @default.
• W3150494001 hasConceptScore W3150494001C2780884295 @default.
• W3150494001 hasConceptScore W3150494001C42219234 @default.
• W3150494001 hasConceptScore W3150494001C530470458 @default.
• W3150494001 hasConceptScore W3150494001C71924100 @default.
• W3150494001 hasLocation W31504940011 @default.
• W3150494001 hasOpenAccess W3150494001 @default.
• W3150494001 hasPrimaryLocation W31504940011 @default.
• W3150494001 hasRelatedWork W1576678846 @default.
• W3150494001 hasRelatedWork W1977887408 @default.
• W3150494001 hasRelatedWork W1981105831 @default.
• W3150494001 hasRelatedWork W2000913440 @default.
• W3150494001 hasRelatedWork W2038053007 @default.
• W3150494001 hasRelatedWork W2149292380 @default.
• W3150494001 hasRelatedWork W2169013235 @default.
• W3150494001 hasRelatedWork W2229648950 @default.
• W3150494001 hasRelatedWork W2346175455 @default.
• W3150494001 hasRelatedWork W2355454616 @default.
• W3150494001 hasRelatedWork W2367470079 @default.
• W3150494001 hasRelatedWork W2391589591 @default.
• W3150494001 hasRelatedWork W2411609258 @default.
• W3150494001 hasRelatedWork W2473183299 @default.
• W3150494001 hasRelatedWork W2582822717 @default.
• W3150494001 hasRelatedWork W2611572809 @default.
• W3150494001 hasRelatedWork W2620339512 @default.
• W3150494001 hasRelatedWork W2899579537 @default.
• W3150494001 hasRelatedWork W2921877470 @default.
• W3150494001 hasRelatedWork W3136727261 @default.
• W3150494001 isParatext "false" @default.
• W3150494001 isRetracted "false" @default.
• W3150494001 magId "3150494001" @default.
• W3150494001 workType "article" @default.